Completing data — refresh the page later to see the latest
1185887-13-1CC(C)(C)[C@H](NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=OZWCCSIUBHCZKOY-GOSISDBHSA-NN-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide is a DEA Schedule I controlled substance. Substances in the DEA Schedule I have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. It is a Hallucinogenic substances substance.
DEA NFLIS-Drug Category -> Synthetic Cannabinoids
DEA Schedule I Controlled Substance -> Hallucinogenic substances
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesADB-CHMINACA is a synthetic cannabinoid agent that is structurally related to ADB-FUBINACA (A234000), a synthetic cannabinoid that is used as a designer drug in illegal products.
1185887-13-1DTXSID801009984